• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

豚鼠的免疫原性及草花粉敏感志愿者对肠溶衣草花粉变应原的耐受性

Immunogenicity in guinea pigs and tolerance in grass pollen-sensitive volunteers of enteric-coated grass pollen allergens.

作者信息

Wheeler A W, Henderson D C, Youlten L J, Al-Janabi I I, Hickman B E, Taylor I H, Moran D M

出版信息

Int Arch Allergy Appl Immunol. 1987;83(4):354-8. doi: 10.1159/000234368.

DOI:10.1159/000234368
PMID:3610349
Abstract

An acid-insoluble, methacrylic acid, methyl methacrylate copolymer (Eudragit L-100) was used to give an enteric coating to a grass pollen extract in order to protect it against gastric degradation. Substantial protection against the degradative effects of simulated gastric secretion was demonstrated using this preparation which was well tolerated by grass pollen-allergic volunteers. The enteric-coated allergen induced a greater secondary antibody response than did an aqueous presentation when administered orally to guinea pigs which had been primed previously by subcutaneous injection. This result indicates that an effective hyposensitisation regimen could consist of a short series of initial parenteral injections, followed by an oral course of the protected allergen.

摘要

一种酸不溶性的甲基丙烯酸与甲基丙烯酸甲酯共聚物(尤特奇L-100)被用于给草花粉提取物包肠溶衣,以保护其免受胃部降解。使用该制剂可有效抵御模拟胃液分泌的降解作用,且草花粉过敏志愿者对其耐受性良好。当对先前经皮下注射致敏的豚鼠口服给药时,肠溶衣过敏原诱导产生的二次抗体反应比水剂更强。这一结果表明,一种有效的减敏方案可以包括一系列短程的初始皮下注射,随后口服受保护的过敏原。

相似文献

1
Immunogenicity in guinea pigs and tolerance in grass pollen-sensitive volunteers of enteric-coated grass pollen allergens.豚鼠的免疫原性及草花粉敏感志愿者对肠溶衣草花粉变应原的耐受性
Int Arch Allergy Appl Immunol. 1987;83(4):354-8. doi: 10.1159/000234368.
2
Oral hyposensitisation with enteric-coated allergens as extension therapy following a basic subcutaneous course of injections.在进行基础皮下注射疗程后,使用肠溶包衣变应原进行口服减敏作为延伸治疗。
Int Arch Allergy Appl Immunol. 1987;84(1):74-8. doi: 10.1159/000234401.
3
Pretreatment IgE sensitization patterns determine the molecular profile of the IgG4 response during updosing of subcutaneous immunotherapy with timothy grass pollen extract.在对 Timothy 草花粉提取物进行皮下免疫治疗的剂量递增过程中,预处理 IgE 致敏模式决定 IgG4 反应的分子特征。
J Allergy Clin Immunol. 2016 Feb;137(2):562-70. doi: 10.1016/j.jaci.2015.05.023. Epub 2015 Jun 30.
4
Evaluation of recombinant and native timothy pollen (rPhl p 1, 2, 5, 6, 7, 11, 12 and nPhl p 4)- specific IgG4 antibodies induced by subcutaneous immunotherapy with timothy pollen extract in allergic patients.对过敏性患者用梯牧草花粉提取物进行皮下免疫治疗诱导产生的重组和天然梯牧草花粉(rPhl p 1、2、5、6、7、11、12和nPhl p 4)特异性IgG4抗体的评估。
Int Arch Allergy Immunol. 2004 Sep;135(1):44-53. doi: 10.1159/000080042. Epub 2004 Jul 30.
5
An alternative allergen:adjuvant formulation potentiates the immunogenicity and reduces allergenicity of a novel subcutaneous immunotherapy product for treatment of grass-pollen allergy.一种替代变应原佐剂配方增强了一种新型皮下免疫治疗产品治疗花粉过敏的免疫原性并降低了其变应原性。
Clin Exp Allergy. 2012 Sep;42(9):1356-68. doi: 10.1111/j.1365-2222.2012.04026.x.
6
Short-term subcutaneous grass pollen immunotherapy under the umbrella of anti-IL-4: A randomized controlled trial.短期皮下草花粉免疫治疗在抗 IL-4 保护伞下:一项随机对照试验。
J Allergy Clin Immunol. 2016 Feb;137(2):452-461.e9. doi: 10.1016/j.jaci.2015.08.046. Epub 2015 Oct 31.
7
Double-blind, placebo-controlled evaluation of grass pollen specific immunotherapy with oral drops administered sublingually or supralingually.舌下或舌上给药的草花粉特异性免疫疗法的双盲、安慰剂对照评估。
Respir Med. 2008 Sep;102(9):1296-304. doi: 10.1016/j.rmed.2008.03.024. Epub 2008 Jun 27.
8
Evaluation of serum IgG4 antibodies specific to grass pollen allergen components in the follow up of allergic patients undergoing subcutaneous and sublingual immunotherapy.在接受皮下和舌下免疫疗法的过敏患者随访中评估针对草花粉过敏原成分的血清IgG4抗体
Vaccine. 2007 Jan 15;25(5):957-64. doi: 10.1016/j.vaccine.2006.08.040. Epub 2006 Sep 11.
9
Clinical and immunological response to oral and subcutaneous immunotherapy with grass pollen extracts. A prospective study.草花粉提取物口服和皮下免疫疗法的临床及免疫反应:一项前瞻性研究。
Eur J Pediatr. 1982 Jul;138(4):341-4. doi: 10.1007/BF00442513.
10
Recombinant allergen-based monitoring of antibody responses during injection grass pollen immunotherapy and after 5 years of discontinuation.注射草花粉免疫治疗期间和停止治疗 5 年后基于重组变应原的抗体应答监测。
Allergy. 2011 Sep;66(9):1174-82. doi: 10.1111/j.1398-9995.2011.02592.x. Epub 2011 Apr 11.

引用本文的文献

1
Formulations for Allergen Immunotherapy in Human and Veterinary Patients: New Candidates on the Horizon.变应原免疫疗法在人类和兽医患者中的制剂:新的候选药物即将出现。
Front Immunol. 2020 Aug 4;11:1697. doi: 10.3389/fimmu.2020.01697. eCollection 2020.
2
Immunotherapy for allergies and asthma: present and future.过敏和哮喘的免疫疗法:现状与未来。
Curr Opin Pharmacol. 2010 Jun;10(3):276-88. doi: 10.1016/j.coph.2010.05.012. Epub 2010 Jun 21.